NDC 80425-0280-01 - Doxycycline Hyclate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0280
- Requested NDC
- 80425-0280-01
- Package NDCs from labels
- 80425-0280-1, 80425-0280-2, 80425-0280-3, 80425-0280-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxycycline Hyclate - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0280-1 | Doxycycline Hyclate | 10 in 1 BOTTLE | CAPSULE | 10 | 3 | |
| 80425-0280-2 | Doxycycline Hyclate | 20 in 1 BOTTLE | CAPSULE | 20 | 3 | |
| 80425-0280-3 | Doxycycline Hyclate | 14 in 1 BOTTLE | CAPSULE | 14 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0280 | DOXYCYCLINE HYCLATE CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 3 | Current NDC, 3 package rows | 20250102_f5ed9293-15f8-ecfa-e053-2a95a90ab6a4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0280-1 | EA - Each | 80425-0280 | 876b650e-7c89-412c-845c-a5193b5fea37 | 1 | 2023-04-07 |
| 80425-0280-2 | EA - Each | 80425-0280 | c97ffa83-0b17-44a7-8839-7bcf1d463802 | 1 | 2023-04-07 |
| 80425-0280-3 | EA - Each | 80425-0280 | 73733f95-7ccf-4f1e-b42a-76fe950577ab | 1 | 2023-07-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Hikma Pharmaceuticals USA Inc. | 9b52e0a7-f024-4d8a-a59e-374946e60b44 | 2025-08-15 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Viona Pharmaceuticals Inc | 763997f0-b35c-43cb-a792-3e0bae589536 | 2025-08-12 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | JG Pharma Inc. | 10b8bf71-4311-41e8-a891-bab8bc86863f | 2025-08-01 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Larken Laboratories, Inc. | 49f82130-6f8a-412c-b625-e75906e74675 | 2025-07-31 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline hyclate | DOXYCYCLINE HYCLATE | Bryant Ranch Prepack | b612d2f5-b703-47f0-b5eb-b66a7aeed577 | 2025-06-27 | Warnings, Adverse reactions | 1649405 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Actavis Pharma, Inc. | a569ba80-ffea-40b2-9fbe-a42810b1fccb | 2025-06-26 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | A-S Medication Solutions | 6772807d-a39e-47ce-9584-a08e7f8940d2 | 2025-06-17 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
| Doxycycline hyclate | DOXYCYCLINE HYCLATE | Asclemed USA, Inc. | bed39bae-64c2-44b4-9c95-682ead4e6738 | 2025-05-31 | Warnings, Adverse reactions | 1649988 1649405 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Asclemed USA, Inc. | a5571acf-3284-4559-8cc0-b4856ac6d94d | 2025-05-31 | Warnings, Adverse reactions | 1649988 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | A-S Medication Solutions | 61195fc6-3fa7-4203-b526-477b48395856 | 2025-05-16 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | A-S Medication Solutions | 9cbd8699-e2c2-40d4-8797-e676f2a10eb2 | 2025-05-16 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Inc. | 7c33c1b8-100e-4df8-be8d-de3eed7ced94 | 2025-04-30 | Warnings, Adverse reactions | 19XTS3T51U |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Inc. | cec4368f-2852-443d-9d6f-7ba95807021b | 2025-04-16 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Chartwell RX, LLC | b3294889-e8f8-42f1-9bd0-13d87572997a | 2025-04-15 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 65cac0b6-3550-48cf-bffa-cf42443c2731 | 2025-04-14 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Mayne Pharma Commercial LLC | cd2ab9b8-9619-4199-8a5d-83377b3274d1 | 2025-04-14 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Coupler LLC | 325d5331-d48e-1bc4-e063-6394a90a65b9 | 2025-04-09 | Warnings, Adverse reactions | 1649405 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Sun Pharmaceutical Industries, Inc. | bff3f426-44fc-4dbf-96df-df44011103e8 | 2025-04-03 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Epic Pharma, LLC | 2b402587-8ecc-4fea-83ad-8071345b6356 | 2025-04-01 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Actavis Pharma, Inc. | c2b08332-3256-4658-965a-ede3d973a388 | 2025-04-01 | Warnings, Adverse reactions | 19XTS3T51U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.